Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children
about
Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesIP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyQuantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values.Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individualsCongenital tuberculosis detected by T-SPOT.TB assay in a male infant after in vitro fertilization and followed up with radiography.Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatmentKinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosisInterferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceSystematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update.Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis.Performance of the QuantiFERON-TB gold interferon gamma release assay among HIV-infected children in Botswana.Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review.Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.
P2860
Q28475371-1ABB0D72-10E5-43CF-9DD4-6F1B969F9DA5Q33905874-2E8C5B9E-912B-47C3-A4EA-CE76295033AAQ34274010-EB465C2A-8717-422F-ADA4-C557D39B71FCQ34299551-A988494E-E763-498A-9455-62C0697F9EF4Q34620314-9EBEBDE5-EBF3-45A2-A8FD-2615263C1C97Q35063982-CE67357B-F1C7-4049-858A-0ED02429BCA6Q35855971-07F757CE-22D3-4BFB-910E-0036689B94D3Q36637982-24DECA9C-9EE2-4E76-9660-90BD1826A3ADQ38190587-9A9FACA3-C1A2-4E6A-881B-F5207CF7CE6EQ38933459-85D63F5D-0121-40DA-A91B-F68D6ED0F105Q40794934-928B2207-7985-4C6E-8B19-1F539C61A333Q44935777-CA7BCDD4-75AF-4E05-8F0F-BB50BC68DE33Q48215149-22230929-2AFC-4312-9CC9-9FF9FF896824
P2860
Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Reversion and conversion of My ...... tment in HIV-infected children
@ast
Reversion and conversion of My ...... tment in HIV-infected children
@en
Reversion and conversion of My ...... ment in HIV-infected children.
@nl
type
label
Reversion and conversion of My ...... tment in HIV-infected children
@ast
Reversion and conversion of My ...... tment in HIV-infected children
@en
Reversion and conversion of My ...... ment in HIV-infected children.
@nl
prefLabel
Reversion and conversion of My ...... tment in HIV-infected children
@ast
Reversion and conversion of My ...... tment in HIV-infected children
@en
Reversion and conversion of My ...... ment in HIV-infected children.
@nl
P2093
P2860
P50
P356
P1476
Reversion and conversion of My ...... tment in HIV-infected children
@en
P2093
Brian Eley
Christine Johannisen
David Beatty
Heather J Zar
Kathryn Wood
Sandy Pienaar
Tom G Connell
P2860
P2888
P356
10.1186/1471-2334-10-138
P577
2010-05-27T00:00:00Z
P5875
P6179
1021950401